Salt-tolerant alpha-amylase mutant and application thereof
By mutating specific amino acids in the α-amylase from Geobacillus stearothermophilus to enhance salt tolerance, the enzyme's activity is significantly improved in high-concentration salt solutions, addressing the limitations of existing α-amylases.
Patent Information
- Application Number
- CN202411383859.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-30
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-09-30
AI Technical Summary
Existing α-amylases exhibit limited salt tolerance, particularly in high concentrations of metal salts such as calcium chloride, magnesium chloride, and sodium bicarbonate, hindering their industrial applications.
A site-directed mutagenesis approach is applied to the α-amylase from Geobacillus stearothermophilus, introducing mutations at specific amino acid positions to convert acidic residues to hydrophobic non-polar amino acids, resulting in a salt-tolerant mutant enzyme with enhanced activity in high-concentration salt solutions.
The mutant α-amylase demonstrates increased enzyme activity by up to 57.4% in high-concentration sodium, magnesium, and calcium ion solutions, optimizing its performance in industrial environments.
Smart Images

Figure CN119060988A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a site-directed mutagenesis and heterologous expression technology of an alpha-amylase gene, in particular to an alpha-amylase mutant with improved tolerance to high-concentration salt and its gene, expression strain and preparation method, belonging to the field of genetic engineering. Background Art
[0002] Starch is a polysaccharide substance widely found in nature. It is the most common form of energy storage in many plants. It plays an important physiological and nutritional role in plants and is also one of the main food sources for humans. Starch molecules are composed of thousands of glucose monomer molecules connected by α-1,4-glycosidic bonds and α-1,6-glycosidic bonds. α-Amylase can break α-1,4-glycosidic bonds inside starch molecules to produce smaller carbohydrate units such as glucose and maltose. Several bacterial α-amylases have been used in industrial applications on a large scale, including Bacillus amyloliquefaciens, Bacillus licheniformis and Bacillus lipophilus. However, the catalytic activity of α-amylase is limited by environmental conditions, such as temperature, pH, metal salts, etc. For high concentrations of metal salts such as calcium chloride, magnesium chloride, sodium bicarbonate, etc., the salt tolerance of existing α-amylases cannot meet the application needs. Summary of the invention
[0003] Purpose of the invention: The purpose of the present invention is to provide an α-amylase mutant with improved salt tolerance and its application.
[0004] Technical solution: The first aspect of the present invention provides a salt-tolerant α-amylase mutant, the amino acid sequence of the α-amylase mutant is obtained by mutation of the sequence shown in SEQ ID NO: 1, and the mutation includes: the glutamic acid at position 47 mutates to phenylalanine, or the glutamic acid at position 202 mutates to phenylalanine, or the glutamic acid at position 248 mutates to phenylalanine, or the aspartic acid at position 352 mutates to valine, or the glutamic acid at position 248 mutates to phenylalanine and the aspartic acid at position 352 mutates to valine.
[0005] The present invention uses α-amylase from Geobacillus stearothermophilus as the starting enzyme, determines the mutation site by 3D modeling of α-amylase, uses point mutation technology to mutate the acidic amino acids on the surface of the protein into hydrophobic non-polar amino acids, and introduces the mutant gene into the host bacteria to express the mutant enzyme body. Through screening, five salt-tolerant α-amylase mutants were finally obtained, and the mutants had higher enzyme activity in high-concentration salt solutions (NaHCO3, MgCl2, NaCl or CaCl2).
[0006] The second aspect of the present invention provides a nucleic acid molecule, which encodes the α-amylase mutant as described in the first aspect, and the nucleotide sequence of the nucleic acid molecule is obtained by base mutation of the sequence shown in SEQ ID NO: 2.
[0007] The third aspect of the present invention provides a vector, the vector comprising the nucleotide sequence as described in the second aspect, the vector being a cloning vector or an expression vector. The vector may be a plasmid or a virus.
[0008] The fourth aspect of the present invention provides a recombinant cell, wherein the recombinant cell comprises the vector as described in the third aspect.
[0009] The fifth aspect of the present invention provides a method for preparing the α-amylase mutant, comprising the following steps:
[0010] (1) using a plasmid with the sequence shown in SEQ ID NO: 2 as a template, using a point mutation primer to perform a PCR reaction to obtain a point mutation gene sequence and a plasmid; using an endonuclease to digest the template plasmid, and then performing a recombination reaction on the enzyme digestion product;
[0011] (2) transferring the expression vector carrying the mutant gene into the host bacteria for fermentation expression;
[0012] (3) Collecting host bacteria expressing the α-amylase mutant, resuspending the bacteria and breaking the cells, and centrifuging and taking the supernatant to obtain a crude enzyme solution containing the α-amylase mutant.
[0013] Preferably, in step (1), the pET22b plasmid carrying the original enzyme gene is used as a template; and the DpnI endonuclease is used to digest the methylated template plasmid.
[0014] Preferably, in step (2), the recombinant product is transformed into E. coli BL21 (DE3) to express the foreign protein.
[0015] Preferably, in step (3), the host bacteria are collected by centrifugation; and the cells are disrupted by ultrasound.
[0016] Preferably, the sequence of the point mutation primer is as shown in Table 1 ("-F" represents the upstream primer, and "-R" represents the downstream primer):
[0017] Table 1 Primer sequences
[0018] Primer name Sequence (5'-3') E47F-F CAATATTTTTTTTGGTATCTGCCGGATGATGGC E47F-R GATACCAAAAAAAATATTGCATCATGGTGCCATT E202F-F TTGGGATTTTAGCCGCAAACTGAGCCGCATTT E202F-R TTGCGGCTAAAATCCCAATCCACGCCATCAAAAT E248F-F GTGACCTTTCTGAAAAACTGGGGCAAATGGT E248F-R TTTCAGAAAGGTCACCACTTCCGGATGATCCAT D352V-F CTGATGAAAGTGCAGCCGACCCTGGCGGTGACC D352V-R CGGCTGCACTTTCATCAGGGTGTTGGTCATCAG
[0019] Preferably, the system of the PCR reaction is as shown in Table 2:
[0020] Table 2 PCR reaction system
[0021] Composition volume 2×ProofastMaxMasterMix 12.5μL 10pmol / μLForwardPrimer 1μL 10pmol / μLReversePrimer 1μL DNA template <50ng ddH2O up to 25 μL
[0022] Preferably, the conditions for the PCR reaction are as shown in Table 3:
[0023] Table 3 PCR reaction conditions
[0024]
[0025]
[0026] Preferably, the DpnI endonuclease digestion conditions are: 37°C for 2h, and the enzyme digestion system is as shown in Table 4:
[0027] Table 4 Enzyme digestion system
[0028] Composition content PCR reaction products 25μl DpI 1μl
[0029] Preferably, the recombination reaction conditions are: 37°C for 1 hour, and the reaction system is as shown in Table 5:
[0030] Table 5 Recombination reaction system
[0031] Composition content DpnI digestion products 4μl 5×UFOBuffer 4μl UvsXase 2μl ddH2O up to 20 μL
[0032] The sixth aspect of the present invention provides a product, characterized in that the product comprises the α-amylase mutant as described in the first aspect, or the nucleic acid molecule as described in the second aspect, or the vector as described in the third aspect, or the recombinant cell as described in the fourth aspect.
[0033] The seventh aspect of the present invention provides the application of the product described in the sixth aspect in food processing, oil extraction, biofuel production, etc.
[0034] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages: 1. The α-amylase mutant has higher salt tolerance, and the enzyme activity in high-concentration sodium ion, magnesium ion, and calcium ion solutions is higher than that of the original enzyme, with an increase of up to 57.4%; 2. The present invention provides a preparation method and application of the mutant; 3. The present invention provides an α-amylase mutant with higher salt tolerance or its encoding gene or corresponding vector or corresponding recombinant cell, which optimizes the application of α-amylase in a high-concentration salt environment. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] Figure 1 It is a diagram showing the enzyme activity effects of wild-type α-amylase and its mutants in different types of high-concentration salt solutions;
[0036] Figure 2 Schematic diagram of the mutation site of α-amylase mutants. DETAILED DESCRIPTION
[0037] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.
[0038] Example 1 A salt-tolerant α-amylase mutant E47F
[0039] The glutamic acid at position 47 of the alpha-amylase nucleotide sequence shown in SEQ ID NO: 2 was mutated to phenylalanine to obtain a salt-tolerant alpha-amylase mutant E47F. The preparation method is as follows:
[0040] 1. Construction of recombinant plasmid
[0041] Plasmids pET-22b and E. coli BL21 (DE3) are both deposited by the applicant and are from commercial sources. The wild-type α-amylase gene from Geobacillus stearothermophilus was synthesized by Jinweizhi (Suzhou) Co., Ltd. The primers used to introduce mutation sites are shown in Table 1 (E47F-F and E47F-R), the PCR reaction system is shown in Table 2, the template for point mutation PCR is the pET-22b plasmid with the wild-type α-amylase gene sequence, and the other components used for point mutation PCR are all from the MutUFOFast Mutagenesis Kit (Nanjing Jujiang Biology). The PCR reaction conditions are shown in Table 3. After the PCR is completed, since the product contains the original template plasmid, in order to prevent it from forming false positive transformants in subsequent transformations, it is digested with DpnI (37°C constant temperature reaction for 2h), and the digestion reaction system is shown in Table 4. After the DpnI digestion reaction is completed, the DpnI digestion product is subjected to a recombination reaction (37°C constant temperature reaction for 1h), and the reaction system is shown in Table 5. The resulting product is a recombinant plasmid containing the designed point mutation, which was confirmed by sequencing by GENEWIZ (Suzhou) Co., Ltd.
[0042] 2. Expression of mutant enzymes and preparation of crude enzyme solution
[0043] Transform the recombinant plasmid into the E.coli BL21 (DE3) host bacteria and spread it on the surface of LB solid culture medium containing 100μg / mL ampicillin, and culture it at 37℃ overnight. Pick a single colony of E. coli and inoculate it into 3mL LB liquid culture medium containing 100μg / mL ampicillin, and culture it at 37℃ for 10h. Inoculate the seed liquid at a 5% inoculum into a 250mL conical flask containing 30mL TB culture medium, and culture it at 37℃ and 200rpm. When the culture reaches 6h, add IPTG to a final concentration of 0.4mM, set the culture temperature to 22℃, and continue to culture for 18h. The fermentation broth was centrifuged at 4000g for 10 min, the bacteria were collected, and resuspended with a preset high concentration salt solution (100g / LNaHCO3, 150g / L MgCl2, 160g / LNaCl, 300g / L CaCl2), and the cells were ultrasonically disrupted for 5-8min until the liquid became slightly clear. The supernatant was taken as the crude enzyme solution of mutant E47F, and the above strain culture and crude enzyme solution preparation experiments were carried out in triplicate.
[0044] Example 2 A salt-tolerant α-amylase mutant E202F
[0045] The glutamic acid at position 202 of the alpha-amylase nucleotide sequence shown in SEQ ID NO: 2 was mutated to phenylalanine to obtain a salt-tolerant alpha-amylase mutant E202F. The preparation method was the same as in Example 1 except that the primers were E202F-F and E202F-R.
[0046] Example 3 A salt-tolerant α-amylase mutant E248F
[0047] The glutamic acid at position 248 of the alpha-amylase nucleotide sequence shown in SEQ ID NO: 2 was mutated to phenylalanine to obtain a salt-tolerant alpha-amylase mutant E248F. The preparation method was the same as in Example 1 except that the primers were E248F-F and E248F-R.
[0048] Example 4 A salt-tolerant α-amylase mutant D352V
[0049] The aspartic acid at position 352 of the alpha-amylase nucleotide sequence shown in SEQ ID NO: 2 was mutated to valine to obtain a salt-tolerant alpha-amylase mutant D352V. The preparation method was the same as in Example 1 except that the primers were D352V-F and D352V-R.
[0050] Example 5 A salt-tolerant α-amylase mutant E248F / D352V
[0051] The glutamic acid at position 248 of the alpha-amylase nucleotide sequence shown in SEQ ID NO: 2 was mutated to phenylalanine, and the aspartic acid at position 352 was mutated to valine to obtain a salt-tolerant alpha-amylase mutant E248F / D352V. The preparation method was the same as in Example 1 except that the primers were E248F-F, E248F-RD352V-F and D352V-R.
[0052] Example 6 Comparison of the enzyme activities of α-amylase and its mutants in different types of high concentration salt solutions
[0053] The cells extracted in Examples 1-5 were resuspended and ultrasonically disrupted using 100 g / L NaHCO3, 150 g / L MgCl2, 160 g / L NaCl, and 300 g / L CaCl2, respectively. The supernatant was obtained by centrifugation and the enzyme activity was determined using the DNS method.
[0054] The DNS enzyme activity determination method is as follows: prepare 0.500, 0.375, 0.250, 0.188, and 0.125 mg / mL glucose solutions respectively, take 150 μL to a clean EP tube, add 150 μL DNS solution respectively, boil in water for 10 minutes, measure the absorbance at 540 nm and draw a standard curve. Add 30 μL crude enzyme solution and 120 μL 1% starch solution to the EP tube, react at 65 ° C for 5 minutes, quickly cool to room temperature, add 150 μL DNS solution to terminate the reaction, and boil in water for 10 minutes. After quickly cooling to room temperature, dilute appropriately with deionized water and measure the absorbance at 540 nm. In addition, take 30 μL crude enzyme solution and add 120 μL deionized water, use the same DNS solution and treatment method as a negative control. The enzyme activity is calculated according to the above method, and 1 enzyme activity is defined as the amount of enzyme that catalyzes the decomposition of 1 μmol of reducing sugar in 1 minute under the set reaction conditions.
[0055] The results are as follows Figure 1 As shown, the enzyme activity of the five mutants of the enzyme in high-concentration salt solution is improved compared with the original enzyme. In 100g / L NaHCO3 solution, the enzyme activity of mutant E248F is 36.0% higher than that of the original enzyme; in 150g / L MgCl2 solution, the enzyme activity of mutant D352V is 57.4% higher than that of the original enzyme; in 160g / L NaCl solution, the enzyme activity of mutant E248F is 27.7% higher; in 300g / L CaCl2 solution, the enzyme activity of mutant E248F is 27.8% higher. The above results show that the five mutants constructed by the present invention improve the enzyme activity of α-amylase in high-concentration sodium ion, magnesium ion and calcium ion solutions.
Claims
1. A salt-tolerant α-amylase mutant, It is characterized in that The amino acid sequence of the α-amylase mutant is obtained by mutation of the sequence shown in SEQ ID NO: 1, wherein the mutation includes: the glutamic acid at position 47 is mutated to phenylalanine, or the glutamic acid at position 202 is mutated to phenylalanine, or the glutamic acid at position 248 is mutated to phenylalanine, or the aspartic acid at position 352 is mutated to valine, or the glutamic acid at position 248 is mutated to phenylalanine and the aspartic acid at position 352 is mutated to valine.
2. A nucleic acid molecule, It is characterized in that The nucleic acid molecule encodes the α-amylase mutant according to claim 1.
3. The nucleic acid molecule according to claim 2, It is characterized in that The nucleotide sequence of the nucleic acid molecule is obtained by base mutation of the sequence shown in SEQ ID NO:
2.
4. A carrier, It is characterized in that The vector comprises the nucleotide sequence of claim 3.
5. The vector according to claim 4, It is characterized in that The vector is a cloning vector or an expression vector.
6. A recombinant cell, It is characterized in that The recombinant cell comprises the vector of claim 4.
7. A method for preparing the α-amylase mutant according to claim 1, It is characterized in that The steps include: (1) Using a plasmid with the sequence shown in SEQ ID NO: 2 as a template, a point mutation primer is used to perform a PCR reaction to obtain a point mutation gene sequence and a plasmid; using an endonuclease to digest the template plasmid, and then performing a recombination reaction on the enzyme digestion product; (2) Transferring the expression vector carrying the mutant gene into the host bacteria for fermentation expression; (3) Collect the host bacteria expressing the α-amylase mutant, resuspend the bacteria, break the cells, and centrifuge to obtain the supernatant to obtain the crude enzyme solution containing the α-amylase mutant.
8. The preparation method according to claim 7, It is characterized in that The endonuclease in step (1) is DpnI.
9. A product, It is characterized in that The product comprises the α-amylase mutant according to claim 1, or the nucleic acid molecule according to any one of claims 2 to 3, or the vector according to claim 4, or the recombinant cell according to claim 6.
10. Use of the product according to claim 9 in food processing, oil extraction, biofuel production, etc.
Citation Information
Patent Citations
Alpha-AmyL (Amylase) mutant with increased activity and coding gene and application thereof
CN106754826A
Application of amylase for hydrolyzing starch under high-salinity condition and method
CN110106217A
High-specific-activity alpha-amylase mutant and application thereof
CN117402856A
Alpha-amylase mutant as well as gene, vector and preparation method thereof
CN117904079A
Endo-beta-1, 4-glucanase mutant as well as gene, carrier and preparation method thereof
CN118165960A
